<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Virol</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Virol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1096-9071</journal-id><journal-id journal-id-type="publisher-id">JMV</journal-id><journal-title-group><journal-title>Journal of Medical Virology</journal-title></journal-title-group><issn pub-type="ppub">0146-6615</issn><issn pub-type="epub">1096-9071</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7436736</article-id><article-id pub-id-type="doi">10.1002/jmv.26416</article-id><article-id pub-id-type="publisher-id">JMV26416</article-id><article-categories><subj-group subj-group-type="overline"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>COVID&#x02010;19 and AIDS: outcomes from the co&#x02010;existence of two global pandemics and the importance of chronic antiretroviral therapy</article-title><alt-title alt-title-type="left-running-head">PATEL <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="jmv26416-cr-0001" contrib-type="author"><name><surname>Patel</surname><given-names>Raj H.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1896-1961</contrib-id><xref ref-type="aff" rid="jmv26416-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jmv26416-cr-0002" contrib-type="author"><name><surname>Acharya</surname><given-names>Arpan</given-names></name><xref ref-type="aff" rid="jmv26416-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jmv26416-cr-0003" contrib-type="author"><name><surname>Mohan</surname><given-names>Mahesh</given-names></name><xref ref-type="aff" rid="jmv26416-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="jmv26416-cr-0004" contrib-type="author" corresp="yes"><name><surname>Byrareddy</surname><given-names>Siddappa N.</given-names></name><xref ref-type="aff" rid="jmv26416-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="jmv26416-aff-0004">
<sup>4</sup>
</xref><xref ref-type="aff" rid="jmv26416-aff-0005">
<sup>5</sup>
</xref><address><email>sid.byrareddy@unmc.edu</email></address></contrib></contrib-group><aff id="jmv26416-aff-0001">
<label><sup>1</sup></label>
<institution>Edward Via College of Osteopathic Medicine</institution>
<city>Monroe</city>
<named-content content-type="country-part">LA</named-content>
<country country="US">USA</country>
</aff><aff id="jmv26416-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Pharmacology and Experimental Neuroscience</named-content>
<institution>University of Nebraska Medical Centre</institution>
<city>Omaha</city>
<named-content content-type="country-part">NE</named-content>
<country country="US">USA</country>
</aff><aff id="jmv26416-aff-0003">
<label><sup>3</sup></label>
<institution>Texas Biomedical Research Institute, Southwest National Primate Research Center</institution>
<city>San Antonio</city>
<named-content content-type="country-part">TX</named-content>
<postal-code>78227</postal-code>
<country country="US">United States</country>
</aff><aff id="jmv26416-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Pathology and Microbiology</named-content>
<institution>University of Nebraska Medical Center</institution>
<city>Omaha</city>
<named-content content-type="country-part">NE</named-content>
<postal-code>68198</postal-code>
<country country="US">USA</country>
</aff><aff id="jmv26416-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Biochemistry and Molecular Biology</named-content>
<institution>University of Nebraska Medical Centre</institution>
<city>Omaha</city>
<named-content content-type="country-part">NE</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Siddappa N. Byrareddy; Associate Professor, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE, USA. Durham Research Center 8052; 58800 Nebraska Medical Center. Omaha, NE 68198&#x02010;5880.<break/>
Email: <email>sid.byrareddy@unmc.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>8</month><year>2020</year></pub-date><elocation-id>10.1002/jmv.26416</elocation-id><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley Periodicals LLC <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JMV-9999-na.pdf"/><abstract><title>Abstract</title><p>The outbreak of coronavirus disease 2019 (COVID&#x02010;19), caused by severe acute respiratory syndrome 2 (SARS&#x02010;CoV&#x02010;2), has created a worldwide pandemic, raising multitude of challenges and uncertainties regarding disease management specific to immunocompromised patient populations. Despite over ~16 million confirmed cases of COVID&#x02010;19 worldwide as of July 25, 2020, there is a dearth of reports describing the co&#x02010;infection of Human Immunodeficiency Virus (HIV) and SARS&#x02010;CoV&#x02010;2. There are various unknowns regarding the simultaneous impact from these two diseases, despite the fact that the majority of patients with acquired immunodeficiency syndrome (AIDS) are immunocompromised and have comorbidities which can predispose them to severe clinical symptoms, and poorer prognosis, from COVID&#x02010;19. A large majority of reports indicate that HIV patients with normal CD4 T&#x02010;cell counts and suppressed viral loads and receiving regular, chronic antiretroviral therapy (cART) do not present with a severe clinical course of COVID&#x02010;19 and may not be at an increased risk of developing SARS&#x02010;CoV&#x02010;2 infection. These favorable indications for HIV patients may be the byproduct of a potential protective factor conferred by antiretroviral therapy which has also been used successfully in previous coronavirus epidemics.</p><p>This article is protected by copyright. All rights reserved.</p></abstract><kwd-group><kwd id="jmv26416-kwd-0001">AIDS</kwd><kwd id="jmv26416-kwd-0002">antiviral</kwd><kwd id="jmv26416-kwd-0003">cART</kwd><kwd id="jmv26416-kwd-0004">co&#x02010;infection</kwd><kwd id="jmv26416-kwd-0005">COVID&#x02010;19</kwd><kwd id="jmv26416-kwd-0006">HIV</kwd><kwd id="jmv26416-kwd-0007">SARS&#x02010;CoV&#x02010;2</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="9"/><word-count count="350"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.7 mode:remove_FC converted:19.08.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="jmv26416-note-0001"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/jmv.26416</p></fn></fn-group></notes></front></article>